## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `ss-31-frozen-shoulder`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `ss-31-frozen-shoulder` v2 · content_hash `aa9f7d6175d959dd…` · thread_head genesis · 26 DIVs
- **thesis (c1):** No published human trials test SS-31 in frozen shoulder or adhesive capsulitis.
  - c4 [human/active] Phase 1/2 human trial of SS-31 in primary mitochondrial myopathy showed dose-dependent exercise improvements.
  - c5 [human/active] SS-31 received FDA approval for Barth syndrome in 2025 based on functional gains.
  - c2 [preclinical/active] SS-31 protects bovine knee cartilage from impact injury in ex vivo models.
  - c3 [preclinical/active] SS-31 reduced osteoarthritis symptoms in guinea pig models per radiographic and histologic scores.
  - c6 [mechanistic/active] SS-31 binds cardiolipin to stabilize mitochondria and reduce ROS while supporting ATP.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `ss-31-frozen-shoulder`
- **title:** SS-31 (Elamipretide) for Frozen Shoulder: Mitochondrial Evidence Review
- **url:** https://miscsubjects.com/a/ss-31-frozen-shoulder
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:02.778Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have Frozen shoulder

Frozen shoulder, also called adhesive capsulitis, involves the shoulder joint capsule becoming inflamed and thickened. Adhesions form inside the capsule. This leads to progressive stiffness and pain that limits range of motion.

The condition often develops in stages. An initial painful phase features inflammation. A freezing phase brings increasing stiffness. A frozen phase shows restricted movement with less pain. A thawing phase sees gradual improvement over months to years.

Degeneration layers include chronic low-grade inflammation, excessive collagen deposition causing fibrosis, reduced blood flow to the capsule, and possible mitochondrial stress in shoulder muscles and connective tissue cells. If mitochondrial function declines, cells produce less ATP and more reactive oxygen species. This can slow tissue repair and prolong the inflammatory state. The capsule and surrounding muscles then stay in a cycle where breakdown outruns natural repair.

No weight-loss drugs appear in scope here. Mechanical load reduction is not a primary factor for the shoulder in the same way it is for the spine, though overall inflammation reduction could indirectly ease joint stress.

## Why SS-31 (Elamipretide) might help you

1. You are reading about **Frozen shoulder** — what breaks down matters before any compound name.
2. **Therefore for you:** If mitochondrial dysfunction is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

SS-31 binds to cardiolipin in the inner mitochondrial membrane. This stabilizes the membrane, reduces excess reactive oxygen species, and supports ATP production. In a shoulder capsule or muscle cell under inflammatory stress, better mitochondrial output could supply energy for repair processes instead of letting oxidative damage accumulate.

If your frozen shoulder shows persistent inflammation or slow healing after months, the mitochondrial layer may contribute. SS-31 focuses on that layer by protecting mitochondria rather than broadly suppressing immune signals or numbing nerves.

## How these fit together

Single-compound focus. SS-31 (Elamipretide) targets the mitochondrial layer. If your condition profile includes a multi-peptide stack in other contexts, siblings would address other layers such as direct anti-fibrotic or vascular support. Here the emphasis stays on mitochondrial bioenergetics as one potential repair pathway.

## What the evidence actually shows

No published human trials test SS-31 specifically in frozen shoulder or adhesive capsulitis (preclinical tier for condition match). Clinical trials of SS-31 exist in other mitochondrial or inflammatory conditions.

Preclinical studies show SS-31 protects cartilage after impact injury in bovine knee models and reduces osteoarthritis symptoms in guinea pig models via radiographic and histologic scores (preclinical). One murine tendinopathy model examined SS-31 in supraspinatus tendon (preclinical). Neuroinflammation and kidney injury models demonstrate reduced oxidative stress and preserved ATP (preclinical).

Human data come from trials in primary mitochondrial myopathy, heart failure, and Barth syndrome. A phase 1/2 trial in primary mitochondrial myopathy reported dose-dependent exercise improvements (human). Barth syndrome received FDA approval in 2025 based on functional gains (human). No shoulder-specific outcomes appear in those trials.

Anecdotal reports on forums mention SS-31 use for general energy or other joint issues but lack controlled data on frozen shoulder resolution (anecdotal).

## What scientists say

Researchers describe SS-31 as a mitochondria-targeted tetrapeptide that improves bioenergetics without affecting healthy mitochondria. Publications note benefits in models of oxidative stress and fibrosis (mechanistic). They emphasize the need for more targeted human studies in musculoskeletal conditions (speculative for frozen shoulder).

## What people say on Reddit

Forum users discuss SS-31 in broader peptide stacks for recovery or energy. Isolated mentions link other peptides to frozen shoulder improvement. Direct SS-31 experiences for this condition remain rare and uncontrolled (anecdotal). Some report subjective energy gains; others note no clear change or mild side effects.

## What people say on X

Posts reference SS-31 clinical progress in heart failure and mitochondrial disorders. One user with a shoulder injury mentioned ongoing SS-31 use alongside other approaches but provided no outcome details (anecdotal). Discussions focus on mitochondrial support in low-vascular tissues rather than frozen shoulder specifically.

## What we do not know

Direct evidence linking SS-31 to frozen shoulder capsule repair or symptom resolution is absent. Human trials have not measured shoulder range of motion, pain scores, or imaging changes with this peptide. Long-term effects on fibrosis or adhesions remain unstudied. Optimal timing relative to disease stage is unknown.

## Safety and limits

In published trials, SS-31 was generally well tolerated. Common reports include mild injection site reactions. Serious adverse events appear infrequent across mitochondrial disease studies (human). It remains investigational outside approved rare-disease uses. Quality and sourcing vary widely for non-clinical material. No data confirm safety or efficacy when combined with physical therapy or other interventions for frozen shoulder.

## Claims (6)

- **c1** [preclinical w=0.5] No published human trials test SS-31 in frozen shoulder or adhesive capsulitis.
  - who_claims: grok/grok-4.3
- **c4** [human w=0.8] Phase 1/2 human trial of SS-31 in primary mitochondrial myopathy showed dose-dependent exercise improvements.
  - who_claims: grok/grok-4.3
  - sources: web:11
- **c5** [human w=0.8] SS-31 received FDA approval for Barth syndrome in 2025 based on functional gains.
  - who_claims: grok/grok-4.3
  - sources: web:3
- **c2** [preclinical w=0.5] SS-31 protects bovine knee cartilage from impact injury in ex vivo models.
  - who_claims: grok/grok-4.3
  - sources: web:16
- **c3** [preclinical w=0.5] SS-31 reduced osteoarthritis symptoms in guinea pig models per radiographic and histologic scores.
  - who_claims: grok/grok-4.3
  - sources: web:17
- **c6** [mechanistic w=0.3] SS-31 binds cardiolipin to stabilize mitochondria and reduce ROS while supporting ATP.
  - who_claims: grok/grok-4.3
  - sources: web:14

## Voxel graph (6 atoms · 11 edges)
- full graph: https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (5)
- chain valid: yes · head: `7ebc2b63807ec666`

### web:3 · news · ok
- title: FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31
- url: https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/
- summary: Reports 2025 FDA approval for Barth syndrome.
- quote: The recent FDA approval of elamipretide is for the treatment of a rare disease...
- claim_ids: c5
- hash: `0347420b479319c8`

### web:11 · pubmed · ok
- title: Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
- url: https://www.neurology.org/doi/10.1212/WNL.0000000000005255
- summary: Human trial results in PMM.
- quote: a dose-dependent improvement in exercise performance was observed
- claim_ids: c4
- hash: `6451b9ec4e68274e`

### web:14 · pubmed · ok
- title: SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Injury
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC9192202/
- summary: Mechanism details on ROS and mitochondria.
- quote: SS-31... decreases mitochondrial reactive oxygen species production and prevents mitochondrial depolarization
- claim_ids: c6
- hash: `7ebc2b63807ec666`

### web:16 · review · ok
- title: SS-31 Cognitive Vitality For Researchers
- url: https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf
- summary: Preclinical cartilage protection data.
- quote: SS-31 treatment immediately post-impact... resulted in chondrocyte viability similar to that of uninjured controls
- claim_ids: c2
- hash: `ff6b364eae5703d4`

### web:17 · other · ok
- title: Therapeutic Efficacy of mitoprotective SS-31 peptide in Osteoarthritis
- url: https://www.ors.org/wp-content/uploads/AM24/2529.pdf
- summary: Guinea pig OA model results.
- quote: significant reduction in cartilage damage and OA symptoms
- claim_ids: c3
- hash: `2740d9b97993e514`

## Provenance (2 model passes)
- chain valid: yes · head: `3bb5032d1444f269`

- write · grok/grok-4.3 · 2026-06-29T23:56 · hash `d8e93df3e149`
- voxel_divide · owner · 2026-07-17T02:42 · hash `3bb5032d1444`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"ss-31-frozen-shoulder","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest ss-31-frozen-shoulder|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim ss-31-frozen-shoulder|tier|assertion`
- **iMessage ask:** `ss-31-frozen-shoulder|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `ss-31-frozen-shoulder`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-frozen-shoulder/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*